Andrzej Czarnecki,
MD, PhD, DSc

Dr. Czarnecki combines unique experience in clinical medicine, research, regulatory authorities, independent consultancy, and industry. Currently, he is the Director and Deputy European Union Qualified Person for Pharmacovigilance at Eli Lilly. He has had a distinguished career in pharmacology, regulation, and pharmacovigilance in regulatory authorities and industry, and as a consultant to public bodies, such as the World Health Organization and for European Union Commission projects and governments. He is a prolific contributor to professional and scientific activities and contributes to the development of medicines policy internationally. Dr. Czarnecki has worked in cardiovascular medicine and research, has practiced medicine and conducted research at the Royal Postgraduate Medical School in London, University of Cambridge, and worked for the former Medicines Control Agency.

Dr. Czarnecki has been involved in educational activities for pre- and post-graduate students at several Universities (Cambridge, London [LSHTM], Surrey and others). He was a Professor of Pharmacoepidemiology and head of Pharmacovigilance and Clinical Trials Departments and authored over 120 papers. He was elected a fellow of the Faculty of Pharmaceutical Medicine and of the International Society of Pharmacoepidemiology and is a member of several professional societies.

Dr. Czarnecki joined DIA in 1992. Throughout the 1990s, he led the DIA expansion into Central/Eastern Europe and championed numerous contacts with regulatory authorities. He has served on the Steering Committees for International Development (1997 – 1999) and for Europe (1996 – 2004), first as a regulator and later as an industry representative, then was appointed Editor-in-Chief of the DIA Forum member magazine. He was 2003 EuroMeeting Chair, and served on the EuroMeeting Programme and Advisory Committees from 2001 – 2007. In recognition of his contributions, Dr. Czarnecki received the DIA Outstanding Service Award in 2004. In 2009, he transformed the DIA Forum into the Global Forum, which he continued to lead until being elected to the DIA Board of Directors in 2013.